Serum D-Dimer, Glycated Serum Protein, and HbA1c Levels in Predicting Macrosomia in Gestational Diabetes Mellitus

Yunxia Quan,1 Yan Wang2 1Department of Clinical Psychology, Shijiazhuang Maternal and Child Health Hospital, Shijiazhuang, 050000, People’s Republic of China; 2Department of Obstetrics, Shijiazhuang Maternal and Child Health Hospital, Shijiazhuang, 050000, People’s Republic of ChinaCorrespondence: Yan Wang, Department of Obstetrics, Shijiazhuang Maternal and Child Health Hospital, No. 305, Huaian West Road, Qiaoxi District, Shijiazhuang, 050000, People’s Republic of China, Email [email protected]: To evaluate the predictive efficacy of serum D-Dimer (D-D), Glycated Serum Protein (GSP), and HbA1c levels for macrosomia in Gestational Diabetes Mellitus (GDM).Methods: A retrospective analysis was conducted on 224 pregnant women diagnosed with GDM from January 2021 to July 2024. Based on neonatal birth weight, 112 women were assigned to the macrosomia group, and 112 women with normal birth weight infants were assigned to the normal group. Serum levels of D-D, GSP, and HbA1c were measured and compared between the two groups. Binary regression analysis and ROC curve analysis were performed to assess the relationship between these biomarkers and the risk of macrosomia.Results: The macrosomia group had significantly higher levels of D-D (4.90 vs 2.98 mg/L), GSP (3.49 vs 3.07 μmol/L), HbA1c (7.49% vs 5.85%), and HOMA-IR (4.35 vs 3.84) compared to the normal group (all p< 0.001). Multivariate regression analysis revealed that D-Dimer (OR = 2.374), Glycated Serum Protein (GSP, OR = 31.890), and HbA1c (OR = 2.482) were significantly associated with the occurrence of macrosomia, even after adjusting for confounders including BMI. ROC curve analysis demonstrated that the combined detection of D-D, GSP, and HbA1c had an AUC of 0.9241, with a sensitivity of 83.93% and specificity of 86.61%, providing higher diagnostic accuracy than single biomarkers.Conclusion: Serum D-D, GSP, and HbA1c levels are significant factors in predicting macrosomia in GDM pregnancies. The combined use of these markers can improve diagnostic accuracy and serve as a valuable tool for early identification of high-risk pregnancies in clinical practice.Keywords: D-Dimer, glycated serum protein, HbA1c, gestational diabetes mellitus, macrosomia, risk prediction

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2025-08-15
Primary Topic
Gestational Diabetes Research and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum D-Dimer, Glycated Serum Protein, and HbA1c Levels in Predicting Macrosomia in Gestational Diabetes Mellitus

Dove Medical Press (Taylor and Francis Group)
Gestational Diabetes Research and Management
article

Serum D-Dimer, Glycated Serum Protein, and HbA1c Levels in Predicting Macrosomia in Gestational Diabetes Mellitus

article en

Abstract

Yunxia Quan,1 Yan Wang2 1Department of Clinical Psychology, Shijiazhuang Maternal and Child Health Hospital, Shijiazhuang, 050000, People’s Republic of China; 2Department of Obstetrics, Shijiazhuang Maternal and Child Health Hospital, Shijiazhuang, 050000, People’s Republic of ChinaCorrespondence: Yan Wang, Department of Obstetrics, Shijiazhuang Maternal and Child Health Hospital, No. 305, Huaian West Road, Qiaoxi District, Shijiazhuang, 050000, People’s Republic of China, Email [email protected]: To evaluate the predictive efficacy of serum D-Dimer (D-D), Glycated Serum Protein (GSP), and HbA1c levels for macrosomia in Gestational Diabetes Mellitus (GDM).Methods: A retrospective analysis was conducted on 224 pregnant women diagnosed with GDM from January 2021 to July 2024. Based on neonatal birth weight, 112 women were assigned to the macrosomia group, and 112 women with normal birth weight infants were assigned to the normal group. Serum levels of D-D, GSP, and HbA1c were measured and compared between the two groups. Binary regression analysis and ROC curve analysis were performed to assess the relationship between these biomarkers and the risk of macrosomia.Results: The macrosomia group had significantly higher levels of D-D (4.90 vs 2.98 mg/L), GSP (3.49 vs 3.07 μmol/L), HbA1c (7.49% vs 5.85%), and HOMA-IR (4.35 vs 3.84) compared to the normal group (all p< 0.001). Multivariate regression analysis revealed that D-Dimer (OR = 2.374), Glycated Serum Protein (GSP, OR = 31.890), and HbA1c (OR = 2.482) were significantly associated with the occurrence of macrosomia, even after adjusting for confounders including BMI. ROC curve analysis demonstrated that the combined detection of D-D, GSP, and HbA1c had an AUC of 0.9241, with a sensitivity of 83.93% and specificity of 86.61%, providing higher diagnostic accuracy than single biomarkers.Conclusion: Serum D-D, GSP, and HbA1c levels are significant factors in predicting macrosomia in GDM pregnancies. The combined use of these markers can improve diagnostic accuracy and serve as a valuable tool for early identification of high-risk pregnancies in clinical practice.Keywords: D-Dimer, glycated serum protein, HbA1c, gestational diabetes mellitus, macrosomia, risk prediction

Dove Medical Press (Taylor and Francis Group)
Good health and well-being
Openalex Percentile: Top 40%
Gestational Diabetes Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.